Financial statements Adamed Pharma

Balance sheet of Adamed Pharma

Company age:
Age:
23 y. 6 m. 18 d.
Share capital:
Share capital:
1 000 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of ADAMED PHARMA

Year
2018
2019
2020
2021
2023
Total assets 1 600 838 086,76 1 825 243 854,87 2 050 439 616,72 2 258 351 070,66 2 727 051 697,22
A. Fixed assets 825 592 470,62 804 620 414,14 881 441 154,78 1 055 790 236,39 1 374 142 216,84
B. Current assets 775 245 616,14 1 020 623 440,73 1 168 998 461,94 1 202 560 834,27 1 352 909 480,38
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 1 600 838 086,76 1 825 243 854,87 2 050 439 616,72 2 258 351 070,66 2 727 051 697,22
A. Equity 1 178 002 072,51 1 462 660 733,54 1 641 707 798,84 1 791 973 642,37 2 234 668 649,91
B. Liabilities and provisions for liabilities 422 836 014,25 362 583 121,33 408 731 817,88 466 377 428,29 492 383 047,31
I. Long-term liabilities 109 641 091,10 40 194 608,05 29 088 525,54 35 401 801,55 39 341 386,58
II. Short-term liabilities 210 144 215,19 200 032 740,98 248 715 155,23 284 163 295,16 270 966 366,35
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.